Healthtech Startups

ABYRX develops synthetic, absorbable surgical biomaterials, including a bone hemostat used to stop bleeding on bone surfaces during surgery. Its products are tissue-free and designed to absorb after implantation for use in surgical and orthopedic procedures.

1 investor

Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.

1 investor

Acacia Health provides home health, hospice, and palliative care services delivered by interdisciplinary clinical teams in patients' homes or facilities across Southern California. The company specializes in high-acuity patient care with remote monitoring and AI-powered tools.

1 investor

Acacium Group operates multiple businesses providing managed services and expertise tailored to improve outcomes for patients and service users. The company offers end-to-end solutions designed to increase organizational capacity and capability.

1 investor

Acadia builds AI agents that automate revenue cycle management workflows for specialty medical practices, handling patient payment collection, insurance payments, inbound referral intake, cost estimates, prior authorizations, and denials. The agents integrate with practice management and EHR systems to speed up collections and reduce administrative time.

1 investor

Acadia is a biopharmaceutical company developing therapies for underserved neurological disorders and rare diseases. The company operates across North America and Europe, leveraging expertise in areas including Parkinson's disease psychosis and Rett syndrome.

1 investor

Acalta develops Patienta, a digital platform for managing and coordinating clinical treatment pathways across care teams. It targets healthcare providers of all sizes — from single practices and MVZs to hospitals and university clinics — and integrates with common KIS, PVS, and OIS systems, with GDPR-compliant hosting in Germany.

1 investor

Accelerated Biosciences commercializes human trophoblast stem cells (hTSC) and derived platforms for therapeutic development, serving pharmaceutical and biotech partners seeking accelerated pathways to clinical products. The company addresses aging and healthcare cost challenges through cell-based therapeutics.

1 investor

Accelerated Diagnostics is developing decentralised diagnostics for human and veterinary markets, with a product launch planned for July 2026.

1 investor

Accelidea provides decision intelligence software for medical device teams, mapping each product decision to its regulatory, quality, engineering, and submission impact from concept to FDA clearance. It targets MedTech companies developing regulated products, building the evidence, traceability, and documentation needed for FDA submission.

1 investor

Accès Vision operates a network of 44 ophthalmology centers across France offering eye care services such as OCT scans, visual field tests, contact lens fitting, laser capsulotomy and iridotomy. The centers work as Secteur 1 conventioned facilities with third-party payment through Social Security and mutual insurance, serving patients aged 6 and up.

1 investor

Access Bio develops in vitro diagnostics technology, producing rapid diagnostic tests, molecular tests, analyzers, and COVID-19 tests (including PCR, serology, and antigen testing) to detect malaria and other diseases. It serves international public health agencies and organizations.

1 investor

Access Esperanza Clinics is a nonprofit provider of affordable sexual and reproductive health care, offering services such as birth control, STI testing, cancer screenings, and exams. It operates four clinics in Hidalgo County, Texas, serving women and men in the local community, with many patients qualifying for free care.

1 investor

Access Health LA is a healthcare organization providing vision services, medical affairs, and behavioral health services.

1 investor

Access Healthcare provides business process and IT services to the healthcare industry, with expertise in revenue cycle management and healthcare operations.

1 investor

Access TeleCare provides a telemedicine platform and cart hardware that connects hospitals and their patients with remote specialists for acute specialty care and behavioral health. Founded by physicians, it designs custom virtual care delivery programs for hospitals along with 24/7 U.S.-based technical support.

1 investor

Access2Bone develops bone graft products containing human tissue-based compositions for orthopedic surgeries. The company's offerings are designed for foot, ankle, and spine fusion procedures.

1 investor

Accession Therapeutics develops cancer treatments by harnessing immune system mechanisms, with a focus on T cell receptor therapies and engineered cell therapies. The company is led by experienced biotech entrepreneurs and scientific experts with a track record in bringing immunological oncology projects to clinical development.

1 investor

AccessOne is a healthcare financing platform that lets providers offer patient payment and financing options with no credit-based exclusions, aimed at improving repayment rates and net yields. It serves healthcare providers in the United States.

1 investor

Rosarium Health provides comprehensive home accessibility and modification services, including safety evaluations and fall prevention, blending clinical expertise with insurance coordination for independent living. The company serves individuals and families seeking to age in place or improve home accessibility through modifications and professional assessment.

1 investor

Accufix Surgical makes the Accu-Joint implant system, an FDA-approved device for treating MTP (big toe) joint disorders such as hallux limitus, hallux rigidus, and arthritis. The implant resurfaces cartilage while preserving bone, offering an alternative to joint fusion or full-resection implants for patients and foot surgeons.

1 investor

Accuity provides software solutions to hospitals for managing clinical documentation standards, regulatory compliance, and healthcare revenue cycle optimization. The company serves over 400 hospital clients across the United States.

1 investor

Accunea develops organ condition monitoring technology that tracks biomarkers of kidney function and metabolism before and after transplantation, providing clinicians with continuous point-of-care data and AI-driven trend analysis. It serves transplant centres and clinicians to assess organ viability and support patient recovery, and integrates with hospital EPR systems.

1 investor

Accurate Home Care LLC provides in-home nursing and personal care services for patients with conditions such as spinal cord injuries, ventilator dependence, and seizure management, as well as those needing help with daily living activities. It also recruits and employs caregivers and nurses, offering training and an online learning portal.

1 investor